705 related articles for article (PubMed ID: 24844687)
1. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.
Bondi MW; Edmonds EC; Jak AJ; Clark LR; Delano-Wood L; McDonald CR; Nation DA; Libon DJ; Au R; Galasko D; Salmon DP
J Alzheimers Dis; 2014; 42(1):275-89. PubMed ID: 24844687
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.
Edmonds EC; Delano-Wood L; Clark LR; Jak AJ; Nation DA; McDonald CR; Libon DJ; Au R; Galasko D; Salmon DP; Bondi MW;
Alzheimers Dement; 2015 Apr; 11(4):415-24. PubMed ID: 24857234
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological Criteria for Mild Cognitive Impairment in the Framingham Heart Study's Old-Old.
Wong CG; Thomas KR; Edmonds EC; Weigand AJ; Bangen KJ; Eppig JS; Jak AJ; Devine SA; Delano-Wood L; Libon DJ; Edland SD; Au R; Bondi MW
Dement Geriatr Cogn Disord; 2018; 46(5-6):253-265. PubMed ID: 30391953
[TBL] [Abstract][Full Text] [Related]
4. Comparing neuropsychological, typical, and ADNI criteria for the diagnosis of mild cognitive impairment in Vietnam-era veterans.
Ly MT; Adler J; Ton Loy AF; Edmonds EC; Bondi MW; Delano-Wood L;
J Int Neuropsychol Soc; 2024 Jun; 30(5):439-447. PubMed ID: 38263745
[TBL] [Abstract][Full Text] [Related]
5. Statistically Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile Analysis.
Eppig JS; Edmonds EC; Campbell L; Sanderson-Cimino M; Delano-Wood L; Bondi MW;
J Int Neuropsychol Soc; 2017 Aug; 23(7):564-576. PubMed ID: 28578726
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
[TBL] [Abstract][Full Text] [Related]
7. Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes?
Clark LR; Delano-Wood L; Libon DJ; McDonald CR; Nation DA; Bangen KJ; Jak AJ; Au R; Salmon DP; Bondi MW
J Int Neuropsychol Soc; 2013 Jul; 19(6):635-45. PubMed ID: 23552486
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological Criteria for Mild Cognitive Impairment and Dementia Risk in the Framingham Heart Study.
Jak AJ; Preis SR; Beiser AS; Seshadri S; Wolf PA; Bondi MW; Au R
J Int Neuropsychol Soc; 2016 Oct; 22(9):937-943. PubMed ID: 27029348
[TBL] [Abstract][Full Text] [Related]
9. Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment.
Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
J Int Neuropsychol Soc; 2014 Sep; 20(8):836-47. PubMed ID: 25156329
[TBL] [Abstract][Full Text] [Related]
10. Data-Driven vs Consensus Diagnosis of MCI: Enhanced Sensitivity for Detection of Clinical, Biomarker, and Neuropathologic Outcomes.
Edmonds EC; Smirnov DS; Thomas KR; Graves LV; Bangen KJ; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW
Neurology; 2021 Sep; 97(13):e1288-e1299. PubMed ID: 34376506
[TBL] [Abstract][Full Text] [Related]
11. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.
Da X; Toledo JB; Zee J; Wolk DA; Xie SX; Ou Y; Shacklett A; Parmpi P; Shaw L; Trojanowski JQ; Davatzikos C;
Neuroimage Clin; 2014; 4():164-73. PubMed ID: 24371799
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.
Wolfsgruber S; Polcher A; Koppara A; Kleineidam L; Frölich L; Peters O; Hüll M; Rüther E; Wiltfang J; Maier W; Kornhuber J; Lewczuk P; Jessen F; Wagner M
J Alzheimers Dis; 2017; 58(3):939-950. PubMed ID: 28527210
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
Podhorna J; Krahnke T; Shear M; Harrison JE;
Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
[TBL] [Abstract][Full Text] [Related]
14. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
16. Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.
Willette AA; Calhoun VD; Egan JM; Kapogiannis D;
Psychiatry Res; 2014 Nov; 224(2):81-8. PubMed ID: 25194437
[TBL] [Abstract][Full Text] [Related]
17. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
18. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC;
Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the Utility of Actuarial Neuropsychological Criteria Across the Continuum of Normal Aging, Mild Cognitive Impairment, and Dementia.
Graves LV; Edmonds EC; Thomas KR; Weigand AJ; Cooper S; Bondi MW
J Alzheimers Dis; 2020; 78(1):371-386. PubMed ID: 32986674
[TBL] [Abstract][Full Text] [Related]
20. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
